Mirikizumab is a biological medication that targets specific proteins in the body to reduce inflammation in ulcerative colitis. It is administered through injections and works by blocking certain inflammatory pathways that contribute to the symptoms of ulcerative colitis.

Azathioprine is an immunosuppressive medication that helps control the immune system’s response. It is taken orally and works by reducing inflammation in the digestive tract. It is commonly used as a standard treatment for ulcerative colitis.

Glucocorticoids are anti-inflammatory medications that help reduce inflammation throughout the body. They work by suppressing the immune system’s response and can quickly improve symptoms of ulcerative colitis. These medications can be taken orally or administered through other methods depending on the specific treatment plan.

Ulcerative Colitis – A chronic inflammatory bowel disease that causes inflammation and ulcers in the digestive tract, primarily affecting the innermost lining of the large intestine and rectum. The condition typically develops over time, with symptoms that can include abdominal pain, diarrhea, rectal bleeding, and fatigue. The inflammation usually begins in the rectum and can spread continuously to other parts of the colon. The disease can alternate between periods of active symptoms (flares) and periods of remission with no symptoms. The exact cause is unknown, but it’s believed to involve an abnormal immune response, genetic factors, and environmental triggers.